CaltechAUTHORS
  A Caltech Library Service

Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor

Zhu, Xiaotian and Hsu, Barbara T. and Rees, Douglas C. (1993) Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. Structure, 1 (1). pp. 27-34. ISSN 0969-2126. https://resolver.caltech.edu/CaltechAUTHORS:20150205-141809743

Full text is not posted in this repository. Consult Related URLs below.

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20150205-141809743

Abstract

Background: The anti-ulcer drug sucrose octasulfate (SOS) binds to fibroblast growth factors (FGFs), proteins which stimulate the growth and differentiation of several cell types, including stomach epithelial cells. It is believed that SOS stabilizes FGFs against acid denaturation in the stomach, thus enhancing their ability to stimulate healing of ulcerated tissue. SOS binds to the same site on FGF as heparin and other proteoglycans, in vivo, FGF must bind to cell-surface proteoglycans or to heparin before it can interact with FGF receptors and stimulate growth. The details of this process are not understood. Results: We report the crystal structure of a 1:1 complex between acidic FGF (aFGF) and SOS at 2.7 Å resolution. SOS binds to a positively charged region of aFGF, largely composed of residues 112–127, and makes contacts primarily with Lys112, Arg116, Lys118, and Arg122. This region is also important in binding heparin. The overall conformation of aFGF is not changed by binding SOS, although the positions of some side chains in the binding site shift by as much as 6 Å. Conclusion: The SOS-FGF crystal structure is consistent with the model that SOS stabilizes FGF by neutralizing several positively charged residues that would destabilize the native structure by electrostatic repulsion. On the basis of this structure, we provide a model for the complex of heparin with an FGF dimer. Such interactions may facilitate FGF receptor dimerization, which may be important in receptor signaling.


Item Type:Article
Related URLs:
URLURL TypeDescription
http://dx.doi.org/10.1016/0969-2126(93)90006-3DOIArticle
http://www.sciencedirect.com/science/article/pii/0969212693900063PublisherArticle
ORCID:
AuthorORCID
Rees, Douglas C.0000-0003-4073-1185
Contact Email Address:phoebe@caltech.edu
Additional Information:© 1993 Current Biology Ltd. Received: 24 May 1993; revised: 2 July 1993. Accepted: 8 July 1993. We thank AJ Chirino for his contributions to the graphics and refinement, T Arakawa and GM Fox of Amgen for providing aFGF, and D Bar-Shalom of Bukh Meditec for the SOS sample. This work was supported by in part by USPHS GM39558 and GM45162 (for the X-ray and computer facilities).
Funders:
Funding AgencyGrant Number
NIHGM39558
NIHGM45162
Subject Keywords:anti-ulcer drugs, fibroblast growth factors, heparin, sucrose octasulfate
Issue or Number:1
Record Number:CaltechAUTHORS:20150205-141809743
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:20150205-141809743
Official Citation:Xiaotian Zhu, Barbara T Hsu, Douglas C Rees, Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor, Structure, Volume 1, Issue 1, 15 September 1993, Pages 27-34, ISSN 0969-2126, http://dx.doi.org/10.1016/0969-2126(93)90006-3. (http://www.sciencedirect.com/science/article/pii/0969212693900063)
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:54453
Collection:CaltechAUTHORS
Deposited By: SWORD User
Deposited On:08 Feb 2015 02:41
Last Modified:03 Oct 2019 07:57

Repository Staff Only: item control page